| Tolerance to alcohol: A critical yet understudied factor in alcohol addiction SK Elvig, MA McGinn, C Smith, MA Arends, GF Koob, LF Vendruscolo Pharmacology Biochemistry and Behavior 204, 173155, 2021 | 77 | 2021 |
| The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission V Chuong, M Farokhnia, S Khom, CL Pince, SK Elvig, R Vlkolinsky, ... JCI insight 8 (12), 2023 | 76 | 2023 |
| Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents CE Wiers, LF Vendruscolo, JW Van der Veen, P Manza, E Shokri-Kojori, ... Science Advances 7 (15), eabf6780, 2021 | 58 | 2021 |
| Oral prescription opioid‐seeking behavior in male and female mice AG Phillips, DJ McGovern, S Lee, K Ro, DT Huynh, SK Elvig, KN Fegan, ... Addiction Biology 25 (6), e12828, 2020 | 31 | 2020 |
| Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies M Farokhnia, CT Rentsch, V Chuong, MA McGinn, SK Elvig, EA Douglass, ... Molecular psychiatry 27 (11), 4642-4652, 2022 | 29 | 2022 |
| Nutritional ketosis as a potential treatment for alcohol use disorder VR Mahajan, SK Elvig, LF Vendruscolo, GF Koob, VL Darcey, MT King, ... Frontiers in Psychiatry 12, 781668, 2021 | 23 | 2021 |
| Converging Evidence from Rodent and Human Studies on the Role of Spironolactone as a Potential Pharmacotherapy for Alcohol Use Disorder M Farokhnia, CT Rentsch, V Chuong, MA McGinn, SK Elvig, EA Douglass, ... Alcohol 109, 83-84, 2023 | | 2023 |
| Converging evidence from human pharmacoepidemiology and rodent psychopharmacology studies on the role of spironolactone as a potential pharmacotherapy for alcohol use disorder M Farokhnia, C Rentsch, V Chuong, A McGinn, S Elvig, E Douglass, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 348-349, 2022 | | 2022 |
